Crispr Therapeutics AG stock forecast
Crispr Therapeutics AG (1CG) Stock Forecast & Price Target
1CG Analyst Ratings
1CG Stock 12 Month Forecast
Average Price Target
€64.32▲(67.64% Upside)Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Mitchell Kapoor | H.C. Wainwright | €71.63 | buy | 86.70%Upside | Reiterated | 11/10/26 | ||
| Gil Blum | Needham | €73.42 | buy | 91.37%Upside | Reiterated | 11/10/26 | ||
| Edward Tenthoff | Piper Sandler | €98.49 | buy | 156.71%Upside | Reiterated | 11/09/26 | ||
| Brian Cheng | J.P. Morgan | €59.99 | buy | 56.36%Upside | Reiterated | 11/09/26 | ||
| Joon Lee | UBS | €46.56 | hold | 21.36%Upside | Reiterated | 11/09/26 | ||
| Yigal Nochomovitz | Citi | €80.58 | buy | 110.04%Upside | Reiterated | 11/08/26 | ||
| Yanan Zhu | Wells Fargo | €67.15→€62.67 | hold | 63.36%Upside | Assigned | 11/04/26 | ||
| Alec Stranahan | Bank of America Securities | €70.73→€71.63 | buy | 86.70%Upside | Reiterated | 11/04/26 | ||
| Luca Issi | RBC Capital | €44.77 | hold | 16.69%Upside | Reiterated | 11/03/26 | ||
| Tyler Van Buren | TD Cowen | €40.29 | hold | 5.02%Upside | Reiterated | 10/21/26 | ||
| Jonathan Miller | Evercore ISI | €68.05 | buy | 77.37%Upside | Reiterated | 08/31/26 | ||
| Maxwell Skor | Morgan Stanley | €53.72 | hold | 40.03%Upside | Reiterated | 08/28/26 | ||
| Sami Corwin | William Blair | ― | buy | ― | Reiterated | 08/28/26 | ||
| Salveen Richter | Goldman Sachs | €42.98→€49.24 | hold | 28.36%Upside | Assigned | 08/10/26 | ||
| Silvan Turkcan | Citizens JMP | €71.63 | buy | 86.70%Upside | Reiterated | 07/22/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Mitchell KapoorH.C. Wainwright | BuyReiterated€71.63 | 11/10/26 | 86.70%Upside | ||
| Gil BlumNeedham | BuyReiterated€73.42 | 11/10/26 | 91.37%Upside | ||
| Edward TenthoffPiper Sandler | BuyReiterated€98.49 | 11/09/26 | 156.71%Upside | ||
| Brian ChengJ.P. Morgan | BuyReiterated€59.99 | 11/09/26 | 56.36%Upside | ||
| Joon LeeUBS | HoldReiterated€46.56 | 11/09/26 | 21.36%Upside | ||
| Yigal NochomovitzCiti | BuyReiterated€80.58 | 11/08/26 | 110.04%Upside | ||
| Yanan ZhuWells Fargo | HoldAssigned€67.15→€62.67 | 11/04/26 | 63.36%Upside | ||
| Alec StranahanBank of America Securities | BuyReiterated€70.73→€71.63 | 11/04/26 | 86.70%Upside | ||
| Luca IssiRBC Capital | HoldReiterated€44.77 | 11/03/26 | 16.69%Upside | ||
| Tyler Van BurenTD Cowen | HoldReiterated€40.29 | 10/21/26 | 5.02%Upside | ||
| Jonathan MillerEvercore ISI | BuyReiterated€68.05 | 08/31/26 | 77.37%Upside | ||
| Maxwell SkorMorgan Stanley | HoldReiterated€53.72 | 08/28/26 | 40.03%Upside | ||
| Sami CorwinWilliam Blair | BuyReiterated | 08/28/26 | ― | ||
| Salveen RichterGoldman Sachs | HoldAssigned€42.98→€49.24 | 08/10/26 | 28.36%Upside | ||
| Silvan TurkcanCitizens JMP | BuyReiterated€71.63 | 07/22/26 | 86.70%Upside |
Best Analysts Covering Crispr Therapeutics AG
Copying Geulah Livshits's trades and holding each position for 3 Months would result in 52.78% of your transactions generating a profit, with an average return of +9.70% per trade.
Copying Alec Stranahan's trades and holding each position for 1 Year would result in 40.00% of your transactions generating a profit, with an average return of +6.44% per trade.
Copying Edward Tenthoff's trades and holding each position for 2 Years would result in 36.00% of your transactions generating a profit, with an average return of -5.17% per trade.
1CG Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 8 | 7 | 10 |
| Buy | 7 | 8 | 7 | 7 | 4 |
| Hold | 6 | 8 | 7 | 9 | 7 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 22 | 25 | 22 | 23 | 21 |
In the current month, 1CG has received 14 Buy Ratings, 7 Hold Ratings, and 0 Sell Ratings. 1CG average Analyst price target in the past 3 months is 64.32.
1CG Financial Forecast
1CG Earnings Forecast
Next quarter’s earnings estimate for 1CG is -EUR 1.05 with a range of -EUR 1.92 to -EUR 0.67. The previous quarter’s EPS was -EUR 1.03. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
1CG Sales Forecast
Next quarter’s sales forecast for 1CG is EUR 10.15M with a range of EUR 0 to EUR 50.66M. The previous quarter’s sales results were EUR 11.34M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

